Increased in vitro cvsteinvl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance

@article{Mewes1996IncreasedIV,
  title={Increased in vitro cvsteinvl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance},
  author={T. Mewes and H. Riechelmann and L. Klimek},
  journal={Allergy},
  year={1996},
  volume={51}
}
In vitro cysteinyl leukotriene (cLT) release from blood leukocytes was measured in eight normal individuals (NI), nine patients with nasal polyps (NP) without aspirin intolerance, and eight patients with NP, asthma, and aspirin intolerance (AI). Blood leukocytes were prestimulated with interleukin‐3 (IL‐3) and incubated with acetylsalicylic acid (ASA) (10 and 100 pglml) together with C5a (10‐‐8 mol/l) for 18 h. cLT release (LTC4, LTD4 and LTE4) from blood leukocytes was measured with a… Expand
Aspirin-induced asthma: advances in pathogenesis and management.
Aspirin-Induced COX-2 Overexpression in Monocytes of Aspirin-Intolerant Patients
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
Nasal secretions in response to acetylsalicylic acid.
Interleukin 3-dependent mediator release in basophils triggered by C5a
Aspirin intolerance in asthma. Detection by oral challenge.
...
1
2
3
...